VUZI Fundamental Analysis - VUZIX CORP

Name: VUZIX CORP (VUZI) Stock
Brand: VUZIX CORP
Rating: 6 (3 reviews)

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to VUZI. VUZI was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. VUZI has a great financial health rating, but its profitability evaluates not so good. VUZI is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

VUZI had negative earnings in the past year.

VUZI had a negative operating cash flow in the past year.

VUZI had negative earnings in each of the past 5 years.

VUZI had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

VUZI has a worse Return On Assets (-106.19%) than 91.13% of its industry peers.

Looking at the Return On Equity, with a value of -115.71%, VUZI is doing worse than 86.29% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-106.19%
ROE	-115.71%
ROIC	N/A

ROA(3y)-91.88%

ROA(5y)-68.19%

ROE(3y)-98.06%

ROE(5y)-72.74%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for VUZI so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

VUZI does not have a ROIC to compare to the WACC, probably because it is not profitable.

VUZI has more shares outstanding than it did 1 year ago.

The number of shares outstanding for VUZI has been increased compared to 5 years ago.

VUZI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 33.88 indicates that VUZI is not in any danger for bankruptcy at the moment.

VUZI's Altman-Z score of 33.88 is amongst the best of the industry. VUZI outperforms 96.77% of its industry peers.

There is no outstanding debt for VUZI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	33.88

ROIC/WACCN/A

WACC9.19%

2.3 Liquidity

VUZI has a Current Ratio of 7.68. This indicates that VUZI is financially healthy and has no problem in meeting its short term obligations.

Looking at the Current ratio, with a value of 7.68, VUZI belongs to the top of the industry, outperforming 91.13% of the companies in the same industry.

VUZI has a Quick Ratio of 6.59. This indicates that VUZI is financially healthy and has no problem in meeting its short term obligations.

The Quick ratio of VUZI (6.59) is better than 90.32% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	7.68
Quick Ratio	6.59

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

VUZI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.77%, which is quite impressive.

The Revenue for VUZI has decreased by -12.75% in the past year. This is quite bad

VUZI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.91% yearly.

EPS 1Y (TTM)33.77%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%37.5%

Revenue 1Y (TTM)-12.75%

Revenue growth 3Y-24.1%

Revenue growth 5Y-2.91%

Sales Q2Q%18.62%

3.2 Future

VUZI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.25% yearly.

The Revenue is expected to grow by 44.01% on average over the next years. This is a very strong growth

EPS Next Y34.19%

EPS Next 2Y17.25%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year15.21%

Revenue Next 2Y44.01%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

VUZI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year VUZI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

VUZI's earnings are expected to grow with 17.25% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y17.25%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for VUZI!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

VUZIX CORP

NASDAQ:VUZI (11/3/2025, 11:06:50 AM)

3.335

-0.02 (-0.45%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupTechnology Hardware & Equipment

GICS IndustryElectronic Equipment, Instruments & Components

Earnings (Last)08-14 2025-08-14/amc

Earnings (Next)11-13 2025-11-13

Inst Owners31.17%

Inst Owner Change-0.13%

Ins Owners6.17%

Ins Owner Change1.83%

Market Cap257.93M

Revenue(TTM)5.53M

Net Income(TTM)-39185800

Analysts82.86

Price Target3.06 (-8.25%)

Short Float %20.36%

Short Ratio5.24

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)14.22%

Min EPS beat(2)10.13%

Max EPS beat(2)18.3%

EPS beat(4)2

Avg EPS beat(4)-4.17%

Min EPS beat(4)-30.72%

Max EPS beat(4)18.3%

EPS beat(8)2

Avg EPS beat(8)-24.1%

EPS beat(12)4

Avg EPS beat(12)-15.7%

EPS beat(16)4

Avg EPS beat(16)-19.37%

Revenue beat(2)1

Avg Revenue beat(2)-2.99%

Min Revenue beat(2)-21.97%

Max Revenue beat(2)15.99%

Revenue beat(4)1

Avg Revenue beat(4)-13.79%

Min Revenue beat(4)-30.92%

Max Revenue beat(4)15.99%

Revenue beat(8)1

Avg Revenue beat(8)-29.77%

Revenue beat(12)3

Avg Revenue beat(12)-20.76%

Revenue beat(16)3

Avg Revenue beat(16)-19.92%

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)9.09%

EPS NY rev (1m)0%

EPS NY rev (3m)11.11%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-29.26%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-15.6%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	46.6
P/FCF	N/A
P/OCF	N/A
P/B	7.62
P/tB	8.61
EV/EBITDA	N/A

EPS(TTM)-0.51

EYN/A

EPS(NY)-0.39

Fwd EYN/A

FCF(TTM)-0.26

FCFYN/A

OCF(TTM)-0.23

OCFYN/A

SpS0.07

BVpS0.44

TBVpS0.39

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-106.19%
ROE	-115.71%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-91.88%

ROA(5y)-68.19%

ROE(3y)-98.06%

ROE(5y)-72.74%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score3

Asset Turnover0.15

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	85.33%
Cap/Sales	41.88%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	7.68
Quick Ratio	6.59
Altman-Z	33.88

F-Score3

WACC9.19%

ROIC/WACCN/A

Cap/Depr(3y)371.21%

Cap/Depr(5y)276.01%

Cap/Sales(3y)109.82%

Cap/Sales(5y)75.83%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)33.77%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%37.5%

EPS Next Y34.19%

EPS Next 2Y17.25%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-12.75%

Revenue growth 3Y-24.1%

Revenue growth 5Y-2.91%

Sales Q2Q%18.62%

Revenue Next Year15.21%

Revenue Next 2Y44.01%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y21.43%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year62.45%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y58.02%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y31.45%

OCF growth 3YN/A

OCF growth 5YN/A

VUZIX CORP / VUZI FAQ

What is the ChartMill fundamental rating of VUZIX CORP (VUZI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to VUZI.

What is the valuation status of VUZIX CORP (VUZI) stock?

ChartMill assigns a valuation rating of 0 / 10 to VUZIX CORP (VUZI). This can be considered as Overvalued.

What is the profitability of VUZI stock?

VUZIX CORP (VUZI) has a profitability rating of 0 / 10.

How financially healthy is VUZIX CORP?

The financial health rating of VUZIX CORP (VUZI) is 8 / 10.

VUZIX CORP (VUZI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

VUZIX CORP / VUZI FAQ

What is the ChartMill fundamental rating of VUZIX CORP (VUZI) stock?

What is the valuation status of VUZIX CORP (VUZI) stock?

What is the profitability of VUZI stock?

How financially healthy is VUZIX CORP?